Antiviral and bivalent vaccine efficacy against an omicron XBB.1.5 isolate

Lancet Infect Dis. 2023 Apr;23(4):402-403. doi: 10.1016/S1473-3099(23)00070-1. Epub 2023 Feb 8.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antiviral Agents* / therapeutic use
  • COVID-19 Vaccines*
  • COVID-19* / prevention & control
  • Humans
  • Vaccines, Combined

Substances

  • Antiviral Agents
  • Vaccines, Combined
  • COVID-19 Vaccines

Supplementary concepts

  • SARS-CoV-2 variants